Atherosclerosis in the HIV and non-HIV setting : detecting and modifying cardiovascular risk

Thesis

Cover

Title page

Contents

General introduction

Chapter 1: Surrogate markers for atherosclerotic disease

Chapter 2: Atherosclerosis measured by B-mode ultrasonography : effect of statin therapy on disease progression

Chapter 3: High frequency of ApoB gene mutations causing familial hypobetalipoproteinemia in patients of Dutch and Spanish descent

Chapter 4: Hepatic and cardiovascular consequences of familial hypobetalipoproteinemia

Chapter 5: Ezetimibe/Simvastatin (Inegy™) in the treatment of hyperlipidemia

Chapter 6: Atherosclerotic vascular disease in HIV : it is not just antiretroviral therapy that hurts the heart!

Chapter 7: Effects of nevirapine as compared to lamivudine on lipids and lipoproteins in HIV-1 uninfected neonates : the SIMBA lipid substudy

Chapter 8: Increased carotid intima-media thickness in HIV-infected patients exposed to protease inhibitors as compared to non-nucleoside reverse transcriptase inhibitors containing combination antiretroviral therapy

Chapter 9: Nevirapine increases high-density lipoprotein by stimulation of apolipoprotein A-I synthesis

Chapter 10: Pharmacokinetics and pharmacodynamics of combined use of lopinavir/ritonavir and rosuvastatin in HIV-infected patients

Summary

Samenvatting

Dankwoord

Stellingen